Campbell & Co. Investment Adviser »

Kiniksa Pharmaceuticals shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals (KNSA) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Kiniksa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2023-09-30 $554k 32k 17.37
2023-06-30 $806k 57k 14.08
2023-03-31 $315k 29k 10.76
2022-12-31 $982k 66k 14.98
2022-09-30 $691k 54k 12.83

More positions owned by Campbell & Co. Investment Adviser

General Mills Common Stock (GIS)
HP Common Stock (HPQ)
Beyond Common Stock (BBY)
Pioneer Natural Resources Common Stock (PXD)
Cencora Common Stock (COR)
Fiserv Common Stock (FI)
Travelers Cos Inc/The Common Stock (TRV)
Hershey Co/The Common Stock (HSY)
Jack in the Box Common Stock (JACK)
Insulet Corp Common Stock (PODD)
Boise Cascade Common Stock (BCC)
Shake Shack Common Stock (SHAK)
Tapestry Common Stock (TPR)
Interpublic Group of Cos Inc/T Common Stock (IPG)
Beacon Roofing Supply Common Stock (BECN)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Kiniksa Pharmaceuticals

Vanguard Group
Fairmount Funds Management
Baker Bros. Advisors
Goldman Sachs Group
Arrowpoint Asset Management
Rice Hall James & Associates
Tang Capital Management
Caption Management
Altitude Crest Partners
Millennium Management
Dimensional Fund Advisors
GMT Capital Corp
Walleye Trading Advisors
D. E. Shaw & Co
Connor, Clark & Lunn Investment Management

View all funds holding Kiniksa Pharmaceuticals